Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a major risk factor leading to chronic liver disease and type 2 diabetes. Here we chart liver metabolic activity and functionality in NAFLD by integrating global transcriptomic data, from human liver biopsies, and metabolic flux data, measured across the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Commun
Autors principals: Hyötyläinen, Tuulia, Jerby, Livnat, Petäjä, Elina M., Mattila, Ismo, Jäntti, Sirkku, Auvinen, Petri, Gastaldelli, Amalia, Yki-Järvinen, Hannele, Ruppin, Eytan, Orešič, Matej
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742839/
https://ncbi.nlm.nih.gov/pubmed/26839171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms9994
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars